Global initiative on late blight (GiLB): a model for collaborative research
An example of a global initiative to resolve a key biological problem facing
potato is the Global Initiative on Late Blight (GiLB). This was formed following
the realisation that the magnitude of the late blight problem requires a global
strategy. Late blight is caused by the fungus
Phytophthora infestans. The
pathogen is showing increasing resistance to chemicals used in developing
countries (and new chemicals are subject to increasing safety regulations). It
also travels easily, providing access to environments where variability can be
increased through sexual hybridisations (Collins, 2000). Organisations such as
the International Potato Center (CIP) are dedicated to improving the health and
well being of disadvantaged populations in the developing world and appreciate
that there is a role for genetic modification (GM) technology in such initiatives.
CIP is playing a key role in delivering links between private and public centre
research and has set up a global strategy for the uptake and deployment of
genetically engineered potatoes when and where appropriate. The initiative is
called potato GENE (Genetic Engineering Network) and currently involves
scientists from 11 developing and three industrialised countries. Four priority
areas have been focused upon, which actually reflect key issues for the
developed as well as developing countries with regard to GMOs:
- strategies for addressing public concerns;
- seed systems and intellectual property;
- gene flow and effects on non-target organisms; and
- health and food safety issues.
The objective is to provide the scientific information necessary for informed
choice. The GM debate in general is opening up and considerable transparency
is emerging through initiatives driven by scientists themselves. The reader is
directed to sites such as http://www.rikilt.wageningen-ur.nl/euprojects/
euprojects.html, where information canbe gathered on EuropeanUnion funded
research programmes such ENTRANSFOOD and GMOCARE which are aimed
at improving information flow and delivering further scientific advances to
assist risk assessment.